EE94 Cost-Effectiveness Analysis of Vaccinating Against Herpes Zoster With Adjuvanted Recombinant Zoster Vaccine in Switzerland
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.346
https://www.valueinhealthjournal.com/article/S1098-3015(22)02550-5/fulltext
Title :
EE94 Cost-Effectiveness Analysis of Vaccinating Against Herpes Zoster With Adjuvanted Recombinant Zoster Vaccine in Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02550-5&doi=10.1016/j.jval.2022.09.346
First page :
Section Title :
Open access? :
No
Section Order :
12154